Načítá se...
Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease
Research suggests that Alzheimer disease (AD) pathophysiology begins prior to the clinical expression of the disease and that biomarker measures may provide direct evidence of this process. As a result, it may be possible to uncouple the diagnosis of AD from the clinical expression of the disease. T...
Uloženo v:
| Vydáno v: | Neurology |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4561233/ https://ncbi.nlm.nih.gov/pubmed/21917767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e318232ac1a |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|